SCHEMBL23861559

SCHEMBL23861559

CC(c1ccc(-c2ccc(C(C)(c3c(O)ccc4ccccc34)c3c(O)ccc4ccccc34)cc2)cc1)(c1c(O)ccc2ccccc12)c1c(O)ccc2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN22 Q9Y2R2 1/20 0.44
▸ HSD17B2 P37059 1/20 0.43
▸ POLB P06746 2/20 0.42
▸ GAA P10253 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ ESR1 P03372 2/20 0.41
▸ ESR2 Q92731 2/20 0.41
▸ CYP1A2 P05177 2/20 0.41
▸ USP2 O75604 1/20 0.41
▸ PAK1 Q13153 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ TAAR1 Q96RJ0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19803934 0.97 ESR1 (0.42) PTPN22HSD17B2POLBGAAMEN1
SCHEMBL23861563 0.95 PTPN22 (0.48) PTPN22HSD17B2POLBGAAMEN1
SCHEMBL23861443 0.90 ESR1 (0.47) PTPN22HSD17B2POLBGAAESR1
SCHEMBL19806874 0.87 ESR1 (0.38) PTPN22HSD17B2POLBGAAMEN1
SCHEMBL23861638 0.85 POLB (0.44) PTPN22HSD17B2POLBGAAMEN1
SCHEMBL23082042 0.83 ESR1 (0.48) HSD17B2POLBGAAESR1ESR2
SCHEMBL23082053 0.82 ESR1 (0.54) HSD17B2ESR1ESR2CYP1A2CYP2C9
SCHEMBL23861411 0.82 ESR1 (0.41) HSD17B2ESR1ESR2CYP1A2CYP2C9
SCHEMBL23861415 0.81 ESR1 (0.47) HSD17B2ESR1ESR2CYP1A2CYP2C9
SCHEMBL19803933 0.80 ESR1 (0.45) HSD17B2ESR1ESR2CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method RER1, NBAS, INTS9 PTPN22 2079/4885HSD17B2 1269/4885POLB 1919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback